US FDA orders new eye risk warnings for Ozempic, Zepbound

RecentNews.uk

The US Food and Drug Administration ‌on Monday informed patients and healthcare providers of a potential increased risk

The FDA said it is requiring GLP-1 drugs such ​as Eli Lilly’s Mounjaro and Zepbound, and Novo Nordisk’s Ozempic and Wego

“FDA’s drug safety communication applies to all medicines with GLP-1 RA activity and does ​not reference any findings sp

How important is this development (US FDA orders new eye risk warnings for Ozempic, Z...) to you?

Tap below to vote and see what others think.